Development of predictive…, …-02-TOOL-01-two-stage

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Announced, not yet open · HORIZON Research and Innovation Actions · two-stage · HORIZON-HLTH-2027-02-TOOL-01-two-stage

Next cut-off

13 Apr '27

in 219 days

Per grant

€7.4M

the call's own average

Grants expected

projects that will be funded

Funding rate

100%

the full cost of the action

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases.
Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases.
Key stakeholders have access to trustworthy Artificial Intelligence (AI) tools to guide the development of multimodal predictive biomarkers of higher accuracy and clinical value when compared to the established practice.
The citizens benefit of better health outcomes thanks to improved clinical guidelines and the implementation of effective biomarker-guided clinical research and personalised healthcare.

Scope:

Biomarkers[1] are invaluable tools for improving patient outcomes, guiding treatment decisions, accelerating personalised medicine, more effective clinical research and the development of better medicines.

Trimmed here, the full scope, expected outcomes and award criteria are on the official topic page ↗.

Cut-offs

What applying costs you

Item	Estimate	Note
Drafting effort	8–10 weeks	short proposal, then a full one
Partner search	4–8 weeks	runs in parallel, and it is the part that slips
Time to first payment	9–12 months	cut-off → evaluation → grant agreement

Item

Estimate

Note

Drafting effort

8–10 weeks

short proposal, then a full one

Partner search

4–8 weeks

runs in parallel, and it is the part that slips

Time to first payment

9–12 months

cut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Where these conditions come from

Two kinds of row. Most are the sentence we read the condition from, quoted out of the call itself. Some say plainly that they are not a quotation but the programme's own rule for this type of action, the EU portal publishes a table of contents where the conditions should be, so for a Research and Innovation Action the rate comes from the rulebook rather than from the fiche.

Condition	Quoted from the call, or the rule behind it
Consortium size	Not quoted from this call — Research and Innovation Actions under the Horizon Europe rules are at least three independent legal entities from three different Member States or Associated Countries, at least one established in a Member State.
Funding rate	Not quoted from this call — Research and Innovation Actions under the Horizon Europe rules are funded at 100% of eligible costs for every participant.

Condition

Quoted from the call, or the rule behind it

Consortium size

Not quoted from this call — Research and Innovation Actions under the Horizon Europe rules are at least three independent legal entities from three different Member States or Associated Countries, at least one established in a Member State.

Funding rate

Not quoted from this call — Research and Innovation Actions under the Horizon Europe rules are funded at 100% of eligible costs for every participant.

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

In context of Horizon Europe

What this call funds

Cut-offs

What applying costs you

Where these conditions come from

Also open in HE

Become the beneficiary.